The role of propranolol with L-carnitine in the prophylactic treatment of cyclic vomiting syndrome
Phase 3
Recruiting
- Conditions
- Cyclic vomiting syndrome.Cyclical vomitingG43.A0
- Registration Number
- IRCT20120716010297N9
- Lead Sponsor
- Esfahan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 104
Inclusion Criteria
cyclic vomiting syndrome with more than two attacks in a month
No seizures
No metabolic diseases
No gastrointestinal diseases
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence of vomiting attacks. Timepoint: Before and during 6 months after the start of the intervention. Method of measurement: Observation.;Severity of vomiting attacks. Timepoint: Before and during 6 months after the start of the intervention. Method of measurement: Visual scale(Score 1 lowest severity and score 10 highest severity of vomiting attacks).
- Secondary Outcome Measures
Name Time Method